The health and safety of our employees, patients, customers and communities is our top priority. Read about our response to COVID-19

Inspire Medical Systems, Inc. to Report First Quarter 2020 Financial Results on May 5, 2020

Download as PDF

MINNEAPOLIS – April 28, 2020 – Inspire Medical Systems, Inc. (NYSE: INSP)
(“Inspire”), a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea, today announced that it will release financial results for the first
quarter 2020 after the close of trading on Tuesday, May 5. Inspire’s management team
will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to
discuss the financial results and recent business developments.

Tuesday, May 5th @ 5:00 p.m. Eastern Time:
Domestic: 877-407-0792
International: 201-689-8263
Conference ID: 13701658
Webcast: http://public.viavid.com/index.php?id=139012

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and
commercialization of innovative and minimally invasive solutions for patients with
obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-
approved neurostimulation technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989